OAR 331-718-0010: Pharmacological Agents for Respiratory Care
Edition: Current OARD snapshotEffective: 2021-01-01Last verified: 2026-09-07
(1) A licensee administering intravenous narcotics, paralytics and opioids under ORS 688.800(3)(a) is prohibited from monitoring the patient and must have another qualified licensed individual present to monitor the patient throughout procedures with intravenous narcotics, paralytics and opioids. (2) All policies, procedures and protocols for respiratory therapists related to administration of intravenous pharmacological agents must be made available to the Office if requested.
Official history and status
Statutory/Other Authority: ORS 676.615, ORS 688.830 & ORS 688.800
Statutes/Other Implemented: ORS 676.615, ORS 688.830, ORS 688.800 & ORS 676.576
History: HLO 12-2020, amend filed 12/30/2020, effective 01/01/2021 HLA 15-2011, f. 12-30-11, cert. ef. 1-1-12
This rule cites
- ORS 688.800(3)(a) — resolved
Cited by
No inbound citations found.
Official source: https://secure.sos.state.or.us/oard/